50 mg
Trade Name
Catafenac
Powder for oral solution
Request Type
New Registration
Drug Type
Generic(Multisource) Drug
Approval Date
SFDA Approved Use
Short-term treatment in the following acute conditions:
• Post-traumatic pain, inflammation and swelling, e.g. due to sprains.
• Post-operative pain, inflammation and swelling, e.g. following dental or orthopedic surgery.
• Painful and/or inflammatory conditions in gynecology, e.g. primary dysmenorrhea or adnexitis.
• Migraine attacks.
• Painful syndromes of the vertebral column.
• Non-articular rheumatism.
• As an adjuvant in severe painful inflammatory infections of the ear, nose, or throat, e.g. pharyngotonsillitis, otitis. In keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. Fever alone is not an indication.
• Post-traumatic pain, inflammation and swelling, e.g. due to sprains.
• Post-operative pain, inflammation and swelling, e.g. following dental or orthopedic surgery.
• Painful and/or inflammatory conditions in gynecology, e.g. primary dysmenorrhea or adnexitis.
• Migraine attacks.
• Painful syndromes of the vertebral column.
• Non-articular rheumatism.
• As an adjuvant in severe painful inflammatory infections of the ear, nose, or throat, e.g. pharyngotonsillitis, otitis. In keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. Fever alone is not an indication.